Market revenue in 2022 | USD 27.6 million |
Market revenue in 2030 | USD 64.5 million |
Growth rate | 11.2% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 52.17% in 2022. Horizon Databook has segmented the Mexico non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
In Mexico, medical devices and diagnostic tests are regulated by the Comision Federal para la Proteccion contra Riesgos Sanitarios (COFEPRIS). All medical devices including clinical laboratory tests intended to be distributed and imported into the city should undergo registration with COFEPRIS.
In Mexico, the rules and regulations for reimbursement of medical diagnostics are not clearly defined. However, it is popular for medical tourism & stem cell treatments and some of them are offered to patients despite a lack of significant scientific validation.
Many companies are stepping into this market. In June 2017, Pathway Genomics recently entered into an agreement with Salud Interactiva. As per the agreement, Pathway Genomic’s NGS-based genetic tests and clinical assays would be provided by Salud Interactiva, which is a healthcare service provider in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico non invasive prenatal testing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account